We are live on ! Find out more
PHK

Point72 Hong Kong Portfolio holdings

AUM $2.18B
1-Year Est. Return 89.02%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+89.02%
3 Year Est. Return
+396.1%
5 Year Est. Return
+490.26%
10 Year Est. Return
+2,256.88%
AUM
$2.88B
AUM Growth
-$192M
Cap. Flow
-$389M
Cap. Flow %
-13.48%
Top 10 Hldgs %
24.09%
Holding
2,616
New
690
Increased
430
Reduced
710
Closed
773

Top Buys

Rank Stock Value
1
XPEV icon
XPeng
XPEV
+$75.5M
2
BEKE icon
KE Holdings
BEKE
+$46.5M
3
NTES icon
NetEase
NTES
+$45.4M
4
EDU icon
New Oriental
EDU
+$39.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 9.75%
2 Consumer Discretionary 7.29%
3 Communication Services 3.78%
4 Financials 3.51%
5 Healthcare 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMTI
1601
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$14K ﹤0.01%
1,011
-1,378
-58% -$27.2K
GHL
1602
DELISTED
Greenhill & Co., Inc.
GHL
$14K ﹤0.01%
+796
New +$13.7K
HZNP
1603
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$14K ﹤0.01%
+131
New +$14.3K
ADNT icon
1604
Adient
ADNT
$1.5B
$13K ﹤0.01%
274
-2,336
-90% -$105K
AMRX icon
1605
Amneal Pharmaceuticals
AMRX
$5.79B
$13K ﹤0.01%
2,681
-337
-11% -$1.68K
ANAB icon
1606
AnaptysBio
ANAB
$1.68B
$13K ﹤0.01%
+366
New +$11.6K
DEI icon
1607
Douglas Emmett
DEI
$1.96B
$13K ﹤0.01%
384
-8,991
-96% -$304K
KALV
1608
DELISTED
KalVista Pharmaceuticals
KALV
$13K ﹤0.01%
+1,005
New +$16K
SHYF
1609
DELISTED
The Shyft Group
SHYF
$13K ﹤0.01%
271
-2,460
-90% -$113K
TOON icon
1610
Kartoon Studios
TOON
$34.9M
$13K ﹤0.01%
+1,282
New +$16.8K
ACA icon
1611
Arcosa
ACA
$7.11B
$12K ﹤0.01%
224
+120
+115% +$6.42K
ALLE icon
1612
Allegion
ALLE
$14.4B
$12K ﹤0.01%
87
-12,698
-99% -$1.66M
BROS icon
1613
Dutch Bros
BROS
$9.26B
$12K ﹤0.01%
231
-8,027
-97% -$446K
KROS icon
1614
Keros Therapeutics
KROS
$221M
$12K ﹤0.01%
+198
New +$9.87K
KTB icon
1615
Kontoor Brands
KTB
$4.26B
$12K ﹤0.01%
227
-2,525
-92% -$135K
NRC icon
1616
NRC Health Common Stock
NRC
$450M
$12K ﹤0.01%
+301
New +$13.1K
RUSHA icon
1617
Rush Enterprises Class A
RUSHA
$6.22B
$12K ﹤0.01%
+335
New +$11.7K
VNDA icon
1618
Vanda Pharmaceuticals
VNDA
$302M
$12K ﹤0.01%
752
+41
+6% +$714
SYRS
1619
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$12K ﹤0.01%
371
-335
-47% -$13.6K
VLDR
1620
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$12K ﹤0.01%
+2,567
New +$15K
IVC
1621
DELISTED
Invacare Corporation
IVC
$12K ﹤0.01%
+4,269
New +$15.7K
CRMT icon
1622
America's Car Mart
CRMT
$26.9M
$11K ﹤0.01%
+105
New +$11.8K
GDEN
1623
DELISTED
Golden Entertainment
GDEN
$11K ﹤0.01%
+208
New +$10.3K
MATW icon
1624
Matthews International
MATW
$739M
$11K ﹤0.01%
+288
New +$10.4K
TIPT icon
1625
Tiptree Inc
TIPT
$675M
$11K ﹤0.01%
+777
New +$10.9K

Similar funds

Point72 Hong Kong's Q4 2021 Portfolio in Review

As of Q4 2021, Point72 Hong Kong held 2,616 positions worth $2.88B, down 6.2% from $3.08B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Point72 Hong Kong withdrew a net $389M in Q4 2021, closing 773 positions and reducing 710 holdings. Its most notable exit was TAL Education Group, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Point72 Hong Kong opened a new position in Riot Platforms worth $20.5M.

  • Point72 Hong Kong's largest Q4 2021 buy was Riot Platforms: 920,169 shares worth $20.5M.
  • Point72 Hong Kong added most to XPeng in Q4 2021, an estimated $75.5M increase.
  • Point72 Hong Kong's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $25.5M.
  • Point72 Hong Kong fully exited TAL Education Group in Q4 2021, selling an estimated $37M.
  • Point72 Hong Kong's ten largest holdings make up 24% of its $2.88B portfolio in Q4 2021.
  • Point72 Hong Kong opened 690 new positions and closed 773 in Q4 2021.
  • Point72 Hong Kong's portfolio value fell 6.2% quarter-over-quarter to $2.88B.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.